In trading on Wednesday, shares of Denali Therapeutics Inc (Symbol: DNLI) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $13.86 per share.

Shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) have been given a consensus recommendation of “Moderate ...

Despite past failures, Denali's extensive pipeline and solid financial runway make it a compelling buy at current low stock ...

One stock that might be an intriguing choice for investors right now is Denali Therapeutics Inc. DNLI. This is because this ...

Cibc World Markets Corp acquired a new position in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange ...

In this article, we are going to take a look at where Denali Therapeutics Inc. (NASDAQ:DNLI) stands against the other companies Bezos is investing in. Since leaving his position as CEO of Amazon ...

Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Denali Therapeutics (DNLI – Research Report) today. The company’s ...

Stifel Nicolaus analyst Paul Matteis reiterated a Buy rating on Denali Therapeutics (DNLI – Research Report) today and set a price target of $37.00. The company’s shares closed yesterday at ...

The latest price target for Denali Therapeutics (NASDAQ:DNLI) was reported by B of A Securities on March 10, 2025. The analyst firm set a price target for $28.00 expecting DNLI to rise to within ...

One stock that might be an intriguing choice for investors right now is Denali Therapeutics Inc. DNLI. This is because this security in the Medical - Biomedical and Genetics space is seeing solid ...